Statistics for State of the art of Smo antagonists for cancer therapy: Advances in the target receptor and new ligand structures

Total visits

views
State of the art of Smo antagonists for cancer therapy: Advances in the target receptor and new ligand structures 0

Total visits per month

views
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0